Nifty
Sensex
:
:
14677.80
48732.55
-18.70 (-0.13%)
41.75 (0.09%)

Pharmaceuticals & Drugs - Domestic

Rating :
61/99

BSE: 506820 | NSE: ASTRAZEN

3842.90
14-May-2021
  • Open
  • High
  • Low
  • Previous Close
  •  3778.50
  •  3870.00
  •  3759.00
  •  3754.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  43366
  •  1658.78
  •  4970.00
  •  2595.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 9,600.13
  • 126.98
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 9,347.60
  • 0.03%
  • 22.53

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 1.45%
  • 19.53%
  • FII
  • DII
  • Others
  • 2.43%
  • 0.83%
  • 0.76%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.43
  • 8.09
  • 13.36

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.52
  • 49.03
  • 21.13

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.19
  • 68.86
  • 40.73

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 93.56
  • 115.69
  • 115.61

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.19
  • 23.19
  • 23.19

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 49.73
  • 60.98
  • 63.32

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • AstraZeneca Pharma India launches Fasenra in India
    21st Apr 2021, 09:42 AM

    Benralizumab (Fasenra) is indicated as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult patients

    Read More
  • AstraZeneca Pharma receives import, market permission for Osimertinib film coated tablets
    11th Mar 2021, 10:21 AM

    The receipt of this permission paves way for the launch of Osimertinib 40mg/80mg film coated tablets into a new disease area in India

    Read More
  • AstraZeneca Pharma receives import, market permission for Dapagliflozin Tablets
    8th Feb 2021, 08:56 AM

    The receipt of this permission paves way for the launch of Dapagliflozin Tablets 10mg into a new disease area to Nephrologists in India

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.